Skip to content
★ Sign in to follow
MS

Matthew Scott Harris

Directeur Médical
Total declarations
36
Company
1
▲ Purchases (1 ops.)
€39k
▼ Sales (2 ops.)
€236k

Latest filing published 04 Aug 2025 for Altimmune, Inc., €5,547.

Filing timeline

BuySale
Matthew Scott Harris

Insider track record

Disclosed buys
1
Disclosed sells
2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Matthew Scott Harris: trading record in brief

Matthew Scott Harris is a declared insider of Altimmune, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 36 filings, for trades running from 31 July 2020 to 31 July 2025.

Both buying and selling appear: 1 purchase worth €39k, against 2 sales worth €236k. On balance, insiders were net sellers of €197k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 21 share grants and 11 option exercises.

The latest filing, published on 4 August 2025, reports a share grant of €5,547 in Altimmune, Inc. The clock since the last published purchase (23 March 2023) now reads 1,327 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Matthew Scott Harris

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    6,337 USD11SEC
    2,018 shares@ US$3.143.2% of flowCommon Stock, par value $0.0001SEC:0001104659-25-073627:0
  • ●
    Chief Medical OfficerExecutivesAltimmune, Inc.
    0SEC
    67,787 shares0Common Stock, par value $0.0001SEC:0001104659-25-022550:0
  • ◇
    Chief Medical OfficerExecutivesAltimmune, Inc.
    0SEC
    9,275 shares0Common Stock, par value $0.0001SEC:0001104659-25-008772:0
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    34,858 USD11SEC
    4,994 shares@ US$6.9818.2% of flowCommon Stock, par value $0.0001SEC:0001104659-25-006841:1
  • ◇
    Chief Medical OfficerExecutivesAltimmune, Inc.
    0SEC
    14,600 shares0Common Stock, par value $0.0001SEC:0001104659-25-006841:0
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    8,039 USD9SEC
    1,486 shares@ US$5.414.0% of flowCommon Stock, par value $0.0001SEC:0001104659-24-084991:0
  • ◇
    Chief Medical OfficerExecutivesAltimmune, Inc.
    0SEC
    6,166 shares0Common Stock, par value $0.0001SEC:0001104659-24-010779:0
  • ◇
    Chief Medical OfficerExecutivesAltimmune, Inc.
    0SEC
    9,275 shares0Common Stock, par value $0.0001SEC:0001104659-24-009540:0
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    1,942 USD11SEC
    691 shares@ US$2.811.0% of flowCommon Stock, par value $0.0001SEC:0001104659-23-086905:0
  • ▲
    Chief Medical OfficerExecutivesAltimmune, Inc.
    42,200 USD26SEC
    10,000 shares@ US$4.2221.1% of flowCommon Stock, par value $0.0001SEC:0001104659-23-036172:0
    Canonical exit: 21 Jun 2023 (T+90)
  • ◇
    Chief Medical OfficerExecutivesAltimmune, Inc.
    0SEC
    7,775 shares0Common Stock, par value $0.0001SEC:0001104659-23-011211:0
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    13,230 USD10SEC
    1,296 shares@ US$10.20856.6% of flowCommon Stock, par value $0.0001SEC:0001104659-23-009974:0
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    7,381 USD9SEC
    1,076 shares@ US$6.863.9% of flowCommon Stock, par value $0.0001SEC:0001104659-22-085624:0
  • ◇
    Chief Medical OfficerExecutivesAltimmune, Inc.
    57,639 USD14SEC
    30,000 shares@ US$1.921329.7% of flowCommon Stock, par value $0.0001SEC:0001104659-22-029462:0
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    12,348 USD12SEC
    1,800 shares@ US$6.866.4% of flowCommon Stock, par value $0.0001SEC:0001104659-22-011519:0
  • ◆
    Chief Medical OfficerExecutivesAltimmune, Inc.
    5,589 USD11SEC
    725 shares@ US$7.70952.7% of flowCommon Stock, par value $0.0001SEC:0001104659-21-101663:0

16 of 16 declarations